Featuring the papers presented at an international meeting on haemophilia, this publication documents the enormous changes having occurred in the field of congenital coagulopathies during the last 25 years. This period saw the first introduction of anti-haemophiliac treatment, the development of increasingly purified coagulation factors leading to an immense improvement of patients' life quality, but also confronted us with the fatal dangers of HIV and hepatitis infections. The contributions deal with the difficulties in diagnosing von Willebrand's Disease, and problems like arthropathy, central nervous system bleeding and factor VIII inhibitors. Different approaches to treatment such as home therapy, long-term therapy and on-demand treatment of children and adolescents, and desmopressin, a nontransfusional treatment, are also discussed.
